T cell metabolism and the immune response

Seminars in Immunology

Volumn 24, Issue 6, 2012, Pages 399-404

  Verbist, Katherine C ^a   Wang, Ruoning ^a   Green, Douglas R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Activation; Differentiation; Memory; Metabolism; Regulation; T cells

Indexed keywords

ANAEROBIC GLYCOLYSIS; CD8+ T LYMPHOCYTE; CELL METABOLISM; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MEMORY T LYMPHOCYTE; NONHUMAN; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH17 CELL; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 84874235310     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.12.006     Document Type: Review

References (77)

1. Gourley T.S., Wherry E.J., Masopust D., Ahmed R. Generation and maintenance of immunological memory. Seminars in Immunology 2004, 16:323-333.
2. Wang R., Green D.R. Metabolic checkpoints in activated T cells. Nature Immunology 2012, 13:907-915.
3. Wang R., Green D.R. Metabolic reprogramming and metabolic dependency in T cells. Immunological Reviews 2012, 249:14-26.
4. Wang R., Green D.R. The immune diet: meeting the metabolic demands of lymphocyte activation. F1000 Biology Reports 2012, 4:9.
5. Guppy M., Greiner E., Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. European Journal of Biochemistry 1993, 212:95-99.
6. Princiotta M.F., Finzi D., Qian S.B., Gibbs J., Schuchmann S., Buttgereit F., et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 2003, 18:343-354.
7. Rathmell J.C., Vander Heiden M.G., Harris M.H., Frauwirth K.A., Thompson C.B. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Molecular Cell 2000, 6:683-692.
8. Fox C.J., Hammerman P.S., Thompson C.B. Fuel feeds function: energy metabolism and the T-cell response. Nature Reviews Immunology 2005, 5:844-852.
9. Plas D.R., Rathmell J.C., Thompson C.B. Homeostatic control of lymphocyte survival: potential origins and implications. Nature Immunology 2002, 3:515-521.
10. Frauwirth K.A., Thompson C.B. Regulation of T lymphocyte metabolism. Journal of Immunology 2004, 172:4661-4665.
11. Vander Heiden M.G., Plas D.R., Rathmell J.C., Fox C.J., Harris M.H., Thompson C.B. Growth factors can influence cell growth and survival through effects on glucose metabolism. Molecular and Cellular Biology 2001, 21:5899-5912.
12. Rathmell J.C., Farkash E.A., Gao W., Thompson C.B. IL-7 enhances the survival and maintains the size of naive T cells. Journal of Immunology 2001, 167:6869-6876.
13. Wieman H.L., Wofford J.A., Rathmell J.C. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Molecular Biology of the Cell 2007, 18:1437-1446.
14. Bradley L.M., Haynes L., Swain S.L. IL-7: maintaining T-cell memory and achieving homeostasis. Trends in Immunology 2005, 26:172-176.
15. Maciver N.J., Jacobs S.R., Wieman H.L., Wofford J.A., Coloff J.L., Rathmell J.C. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. Journal of Leukocyte Biology 2008, 84:949-957.
16. Wofford J.A., Wieman H.L., Jacobs S.R., Zhao Y., Rathmell J.C. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 2008, 111:2101-2111.
17. Kerdiles Y.M., Beisner D.R., Tinoco R., Dejean A.S., Castrillon D.H., DePinho R.A., et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nature Immunology 2009, 10:176-184.
18. Feng X., Wang H., Takata H., Day T.J., Willen J., Hu H. Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nature Immunology 2011, 12:544-550.
19. Kuo C.T., Veselits M.L., Leiden J.M. LKLF: a transcriptional regulator of single-positive T cell quiescence and survival. Science 1997, 277:1986-1990.
20. Grayson J.M., Murali-Krishna K., Altman J.D., Ahmed R. Gene expression in antigen-specific CD8+ T cells during viral infection. Journal of Immunology 2001, 166:795-799.
21. Wu J., Lingrel J.B. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 2004, 23:8088-8096.
22. Buckley A.F., Kuo C.T., Leiden J.M. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nature Immunology 2001, 2:698-704.
23. Takada K., Wang X., Hart G.T., Odumade O.A., Weinreich M.A., Hogquist K.A., et al. Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells. Journal of Immunology 2011, 186:775-783.
24. Weinreich M.A., Takada K., Skon C., Reiner S.L., Jameson S.C., Hogquist K.A. KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 2009, 31:122-130.
25. Hart G.T., Hogquist K.A., Jameson S.C. Kruppel-like factors in lymphocyte biology. Journal of Immunology 2012, 188:521-526.
26. Brand K. Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochemical Journal 1985, 228:353-361.
27. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
28. Roos D., Loos J.A. Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II: relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation. Experimental Cell Research 1973, 77:127-135.
29. Greiner E.F., Guppy M., Brand K. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. Journal of Biological Chemistry 1994, 269:31484-31490.
30. Miller E.S., Klinger J.C., Akin C., Koebel D.A., Sonnenfeld G. Inhibition of murine splenic T lymphocyte proliferation by 2-deoxy-d-glucose-induced metabolic stress. Journal of Neuroimmunology 1994, 52:165-173.
31. Jones R.G., Thompson C.B. Revving the engine: signal transduction fuels T cell activation. Immunity 2007, 27:173-178.
32. Marelli-Berg F.M., Fu H., Mauro C. Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T-cell-mediated immunity. Immunology 2012, 136:363-369.
33. Sagone A.L., LoBuglio A.F., Balcerzak S.P. Alterations in hexose monophosphate shunt during lymphoblastic transformation. Cellular Immunology 1974, 14:443-452.
34. Chiaradonna F., Gaglio D., Vanoni M., Alberghina L. Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts. Biochimica et Biophysica Acta 2006, 1757:1338-1356.
35. Chen C.Y., Liu T.Z., Chen C.H., Wu C.C., Cheng J.T., Yiin S.J., et al. Isoobtusilactone A-induced apoptosis in human hepatoma Hep G2 cells is mediated via increased NADPH oxidase-derived reactive oxygen species (ROS) production and the mitochondria-associated apoptotic mechanisms. Food and Chemical Toxicology 2007, 45:1268-1276.
36. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
37. Frauwirth K.A., Thompson C.B. Activation and inhibition of lymphocytes by costimulation. Journal of Clinical Investigation 2002, 109:295-299.
38. Wang R., Dillon C.P., Shi L.Z., Milasta S., Carter R., Finkelstein D., et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2011, 35:871-882.
39. Macintyre A.N., Finlay D., Preston G., Sinclair L.V., Waugh C.M., Tamas P., et al. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 2011, 34:224-236.
40. Deberardinis R.J., Lum J.J., Thompson C.B. Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. Journal of Biological Chemistry 2006, 281:37372-37380.
41. Yaqoob P., Calder P.C. Glutamine requirement of proliferating T lymphocytes. Nutrition 1997, 13:646-651.
42. Parry R., Smith G., Reif K., Sansom D.M., Ward S. Activation of the PI3K effector protein kinase B following ligation of CD28 or Fas. Biochemical Society Transactions 1997, 25:S589.
43. Summers S.A., Yin V.P., Whiteman E.L., Garza L.A., Cho H., Tuttle R.L., et al. Signaling pathways mediating insulin-stimulated glucose transport. Annals of the New York Academy of Sciences 1999, 892:169-186.
44. Ueki K., Yamamoto-Honda R., Kaburagi Y., Yamauchi T., Tobe K., Burgering B.M., et al. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. Journal of Biological Chemistry 1998, 273:5315-5322.
45. Barthel A., Okino S.T., Liao J., Nakatani K., Li J., Whitlock J.P., et al. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. Journal of Biological Chemistry 1999, 274:20281-20286.
46. Jacobs S.R., Herman C.E., Maciver N.J., Wofford J.A., Wieman H.L., Hammen J.J., et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. Journal of Immunology 2008, 180:4476-4486.
47. Gottlob K., Majewski N., Kennedy S., Kandel E., Robey R.B., Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes and Development 2001, 15:1406-1418.
48. Deprez J., Vertommen D., Alessi D.R., Hue L., Rider M.H. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. Journal of Biological Chemistry 1997, 272:17269-17275.
49. Van Schaftingen E., Hers H.G. Phosphofructokinase 2: the enzyme that forms fructose 2,6-bisphosphate from fructose 6-phosphate and ATP. Biochemical and Biophysical Research Communications 1981, 101:1078-1084.
50. Peter C., Waldmann H., Cobbold S.P. mTOR signalling and metabolic regulation of T cell differentiation. Current Opinion in Immunology 2010, 22:655-661.
51. Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nature Reviews Immunology 2012, 12:325-338.
52. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews Molecular Cell Biology 2011, 12:21-35.
53. Lopez-Rios F., Sanchez-Arago M., Garcia-Garcia E., Ortega A.D., Berrendero J.R., Pozo-Rodriguez F., et al. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Research 2007, 67:9013-9017.
54. Finlay D.K., Rosenzweig E., Sinclair L.V., Feijoo-Carnero C., Hukelmann J.L., Rolf J., et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. Journal of Experimental Medicine 2012, 209:2441-2453.
55. Waickman A.T., Powell J.D. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunological Reviews 2012, 249:43-58.
56. Michalek R.D., Gerriets V.A., Nichols A.G., Inoue M., Kazmin D., Chang C.Y., et al. Estrogen-related receptor-alpha is a metabolic regulator of effector T-cell activation and differentiation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:18348-18353.
57. Huang C.Y., Bredemeyer A.L., Walker L.M., Bassing C.H., Sleckman B.P. Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse. European Journal of Immunology 2008, 38:342-349.
58. Lin C.Y., Loven J., Rahl P.B., Paranal R.M., Burge C.B., Bradner J.E., et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151:56-67.
59. Nie Z., Hu G., Wei G., Cui K., Yamane A., Resch W., et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012, 151:68-79.
60. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. Journal of Immunology 2011, 186:3299-3303.
61. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. Journal of Experimental Medicine 2011, 208:1367-1376.
62. Semenza G.L. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148:399-408.
63. Dang E.V., Barbi J., Yang H.Y., Jinasena D., Yu H., Zheng Y., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
64. Montoya M.C., Luscinskas F.W., del Pozo M.A., Aragones J., de Landazuri M.O. Reduced intracellular oxidative metabolism promotes firm adhesion of human polymorphonuclear leukocytes to vascular endothelium under flow conditions. European Journal of Immunology 1997, 27:1942-1951.
65. Sinclair L.V., Finlay D., Feijoo C., Cornish G.H., Gray A., Ager A., et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nature Immunology 2008, 9:513-521.
66. Weng N.P., Araki Y., Subedi K. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nature Reviews Immunology 2012, 12:306-315.
67. Intlekofer A.M., Takemoto N., Wherry E.J., Longworth S.A., Northrup J.T., Palanivel V.R., et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nature Immunology 2005, 6:1236-1244.
68. van der Windt G.J., Everts B., Chang C.H., Curtis J.D., Freitas T.C., Amiel E., et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 2012, 36:68-78.
69. Hardie D.G., Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 2006, 21:48-60.
70. Buzzai M., Bauer D.E., Jones R.G., Deberardinis R.J., Hatzivassiliou G., Elstrom R.L., et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 2005, 24:4165-4173.
71. Jones R.G., Plas D.R., Kubek S., Buzzai M., Mu J., Xu Y., et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Molecular Cell 2005, 18:283-293.
72. 2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabolism 2005, 2:21-33.
73. 2+ in T lymphocytes. Journal of Experimental Medicine 2006, 203:1665-1670.
74. Pearce E.L., Walsh M.C., Cejas P.J., Harms G.M., Shen H., Wang L.S., et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009, 460:103-107.
75. Araki K., Turner A.P., Shaffer V.O., Gangappa S., Keller S.A., Bachmann M.F., et al. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108-112.
76. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., Roncarolo M.G. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. Journal of Immunology 2006, 177:8338-8347.
77. Battaglia M., Stabilini A., Roncarolo M.G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005, 105:4743-4748.